Matinas BioPharma Holdings, Inc. (MTNB)
0.1842
0.00 (0.00%)
USD |
NYAM |
Sep 09, 10:53
Matinas BioPharma Holdings Total Liabilities (Quarterly) : 1.612M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.612M |
| March 31, 2026 | 2.852M |
| December 31, 2025 | 2.378M |
| September 30, 2025 | 3.235M |
| June 30, 2025 | 3.749M |
| March 31, 2025 | 5.765M |
| December 31, 2024 | 5.051M |
| September 30, 2024 | 4.798M |
| June 30, 2024 | 5.262M |
| March 31, 2024 | 5.052M |
| December 31, 2023 | 46.33M |
| September 30, 2023 | 6.641M |
| June 30, 2023 | 6.171M |
| March 31, 2023 | 5.637M |
| December 31, 2022 | 42.23M |
| September 30, 2022 | 8.927M |
| June 30, 2022 | 9.567M |
| March 31, 2022 | 8.103M |
| December 31, 2021 | 8.833M |
| September 30, 2021 | 8.731M |
| June 30, 2021 | 7.068M |
| March 31, 2021 | 5.794M |
| December 31, 2020 | 7.237M |
| September 30, 2020 | 6.601M |
| June 30, 2020 | 6.262M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.51M |
| December 31, 2019 | 7.189M |
| September 30, 2019 | 6.835M |
| June 30, 2019 | 7.796M |
| March 31, 2019 | 7.566M |
| December 31, 2018 | 3.802M |
| September 30, 2018 | 4.112M |
| June 30, 2018 | 3.517M |
| March 31, 2018 | 3.056M |
| December 31, 2017 | 3.742M |
| September 30, 2017 | 3.739M |
| June 30, 2017 | 2.592M |
| March 31, 2017 | 3.172M |
| December 31, 2016 | 2.666M |
| September 30, 2016 | 2.585M |
| June 30, 2016 | 2.567M |
| March 31, 2016 | 2.525M |
| December 31, 2015 | 2.334M |
| September 30, 2015 | 2.908M |
| June 30, 2015 | 3.233M |
| March 31, 2015 | 3.405M |
| December 31, 2014 | 1.134M |
| September 30, 2014 | 1.043M |
| June 30, 2014 | 0.9058M |
| March 31, 2014 | 0.717M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.412M |
| Shareholders Equity (Quarterly) | 1.80M |
| Debt to Equity Ratio | 0.0033 |
| Current Ratio | 0.8467 |
| Net Debt Paydown Yield | 13.81% |